Compounds > arginyl-glycyl-aspartic acid
Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Deficiency of GP 2b 3a Complex

arginyl-glycyl-aspartic acid has been researched along with Deficiency of GP 2b 3a Complex in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (77.78)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clofent-Sanchez, G; Jacobin, MJ; Laroche-Traineau, J; Little, M; Nurden, A; Peter, K; Pouns, O; Robert, R1
Cox, AD; Devine, DV1
Brisson, C; Cazenave, JP; Gachet, C; Garaud, JC; Hanau, D; Ohlmann, P; Schmitt, DA; Spehner, D1
Irie, A; Kamata, T; Takada, Y; Tokuhira, M1
Bron, N; Gouon, V; Guinet, JM; Kieffer, N; Melchior, C; Michels, S1
Basani, RB; Bennett, JS; Brown, DL; Poncz, M; Vilaire, G1
Israels, SJ; McNicol, A; Pampolina, C; Shibou, TS1
Bajt, ML; Berndt, MC; Frelinger, AL; Ginsberg, MH; Loftus, JC1
Kunicki, TJ1

Reviews

1 review(s) available for arginyl-glycyl-aspartic acid and Deficiency of GP 2b 3a Complex

ArticleYear
The molecular biology of platelet membrane glycoproteins.
    Transfusion medicine reviews, 1990, Volume: 4, Issue:2

    Topics: Bernard-Soulier Syndrome; Extracellular Matrix Proteins; Humans; Integrins; Oligopeptides; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Very Late Antigen; Receptors, Vitronectin; Thrombasthenia

1990

Other Studies

8 other study(ies) available for arginyl-glycyl-aspartic acid and Deficiency of GP 2b 3a Complex

ArticleYear
Improving selection of alphaIIbbeta3-binding phage antibodies with increased reactivity derived from immunized donors.
    Clinical immunology (Orlando, Fla.), 2003, Volume: 108, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Autoantibodies; CHO Cells; Clone Cells; Complementarity Determining Regions; Cricetinae; Female; Humans; Immunization; Immunoglobulin Heavy Chains; Immunoglobulin Light Chains; Male; Middle Aged; Mutation; Oligopeptides; Peptide Library; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Somatic Hypermutation, Immunoglobulin; Spleen; Thrombasthenia; Tissue Donors

2003
Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
    Blood, 1994, Feb-15, Volume: 83, Issue:4

    Topics: Adenosine Diphosphate; Amino Acid Sequence; Antibodies, Monoclonal; Antigens, CD; Arachidonic Acid; Blood Platelets; Calcimycin; Collagen; Epinephrine; Fibrinogen; Fibronectins; Flow Cytometry; Humans; In Vitro Techniques; Kinetics; Membrane Glycoproteins; Membrane Proteins; Oligopeptides; Platelet Activation; Platelet Membrane Glycoproteins; Reference Values; Tetradecanoylphorbol Acetate; Thrombasthenia; Thrombin; Thrombospondins; Time Factors; Transglutaminases

1994
Alpha IIb beta 3 integrin dissociation induced by EDTA results in morphological changes of the platelet surface-connected canalicular system with differential location of the two separate subunits.
    The Journal of cell biology, 1993, Volume: 120, Issue:4

    Topics: Blood Platelets; Cytoplasm; Edetic Acid; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Integrins; Macromolecular Substances; Oligopeptides; Platelet Membrane Glycoproteins; Temperature; Thrombasthenia

1993
Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3).
    The Journal of biological chemistry, 1996, Aug-02, Volume: 271, Issue:31

    Topics: Amino Acid Sequence; Animals; Antibodies; Binding Sites; CHO Cells; Cricetinae; Fibrinogen; Humans; Immunochemistry; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligopeptides; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombasthenia

1996
Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for alpha v beta 3 postreceptor signaling events.
    Cell adhesion and communication, 1996, Volume: 4, Issue:1

    Topics: Alanine; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antigens, CD; Cell Adhesion; CHO Cells; Cricetinae; Cytoskeleton; Extracellular Matrix Proteins; Fibrinogen; Genetic Complementation Test; Humans; Integrin beta3; Molecular Sequence Data; Oligopeptides; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Point Mutation; Proline; Protein Binding; Receptors, Vitronectin; Recombinant Fusion Proteins; Sequence Alignment; Serine; Signal Transduction; Thrombasthenia; Transfection; Vitronectin; von Willebrand Factor

1996
A Leu117-->Trp mutation within the RGD-peptide cross-linking region of beta3 results in Glanzmann thrombasthenia by preventing alphaIIb beta3 export to the platelet surface.
    Blood, 1997, Oct-15, Volume: 90, Issue:8

    Topics: Alleles; Amino Acid Sequence; Animals; Blood Platelets; COS Cells; Flow Cytometry; Humans; Infant; Leucine; Molecular Sequence Data; Mutation; Oligopeptides; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Surface Properties; Thrombasthenia; Tryptophan

1997
Incorporation of map kinases into the platelet cytoskeleton.
    Thrombosis research, 2001, Jul-01, Volume: 103, Issue:1

    Topics: Adult; Blood Platelets; Cytochalasin D; Cytoskeleton; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Oligopeptides; Phosphorylation; Platelet Activation; Thrombasthenia; Thrombin

2001
A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site.
    The Journal of biological chemistry, 1992, Feb-25, Volume: 267, Issue:6

    Topics: Amino Acid Sequence; Amino Acids; Animals; Antibodies, Monoclonal; Base Sequence; Binding Sites; CHO Cells; Chromatography, Affinity; Cricetinae; DNA; Fibrinogen; Flow Cytometry; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Oligopeptides; Platelet Membrane Glycoproteins; Polymerase Chain Reaction; Recombinant Proteins; RNA; Thrombasthenia

1992